PROTEIN KINASE INHIBITORS

摘要

The compounds of Formula (VIII) with absolute configuration R or S, as well as pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein the variables are described herein. The pharmaceutical compositions which comprise the compounds of Formula (VIII), and methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation are provided.